Anesthesiology and Pulmonary Medicine
2011 Louis-Jeantet Prize for Medicine
January 26, 2011 10:35 am | by EurekAlert | News | Comments(European Molecular Biology Organization) The 2011 2011 Louis-Jeantet Prize for Medicine is awarded to the German biologist Stefan Jentsch, a director at the Max-Planck Institute of Biochemistry in Martinsried, and to the Norwegian neurobiologists Edvard and May-Britt Moser, director and...
The American Association for Cancer Research Hosts its 102nd Annual Meeting
January 25, 2011 8:32 am | by AACR | News | CommentsThe deadline for media housing requests for the AACR 102nd Annual Meeting 2011 is Friday, Feb. 25. A limited number of rooms have been set aside for editors and reporters, and we cannot guarantee that housing will be available after that date.
If Hospitals Want a Competitive Advantage - Use Brain Monitors in Surgeries Requiring Sedation says Renowned Anesthesiologist
January 25, 2011 6:33 am | by Bio-Medicine.Org | News | CommentsNEWPORT BEACH, Calif., Jan. 25, 2011 /- Every business needs a competitive advantage over its rivals. Some use a cost advantage; others use a differentiation advantage. Hospitals are not immune from the constant struggle to attract and retain patients and doctors. Dr. Barry Friedberg says...
Chopin's hallucinations were probably caused by epilepsy
January 25, 2011 3:34 am | by EurekAlert | News | Comments(BMJ-British Medical Journal) The composer Frederic Chopin, who regularly hallucinated, probably had temporal lobe epilepsy throughout his short life, reveals research published online in Medical Humanities. Hallucinations typically feature in seizure disorders, they say.
Mylan Announces Caduet® Settlement Agreement
January 25, 2011 3:33 am | by Bio-Medicine.Org | News | CommentsPITTSBURGH, Jan. 25, 2011 /- Mylan Inc. (Nasdaq: MYL ) today announced that it has entered into a settlement agreement with Pfizer Inc. resolving litigation related to Caduet® Tablets, 2.5 mg/10, 2.5 mg/20 mg, 2.5 mg/40 mg, 5 mg/10 mg, 5 mg/20 mg, 5 mg/40 mg, 5 mg/80 mg, 10 mg/10 mg,...
Study examines earlier use of heart pumps in growing group of heart failure patients
January 24, 2011 11:34 am | by EurekAlert | News | Comments(University of Michigan Health System) The University of Michigan Cardiovascular Center and the University of Pittsburgh have been awarded $13.3 million to explore the potential benefits of heart devices for the large and growing group of Americans with heart failure. The NIH and...
Mylan's Matrix Receives Approval for Generic Version of Protonix® Delayed-release Tablets
January 24, 2011 11:34 am | by Bio-Medicine.Org | News | CommentsPITTSBURGH, Jan. 24, 2011 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Pantoprazole Sodium Delayed-release (DR)...
Survey Finds Patients Oppose Prescription Mandate for OTC Medicines Containing Pseudoephedrine
January 24, 2011 11:34 am | by Bio-Medicine.Org | News | CommentsWASHINGTON, Jan. 24, 2011 /PRNewswire-USNewswire/ -- More than 300 million Americans get the common cold, and up to 70 million get the flu annually. But for the 60 million people who also have asthma and allergies, a cold or flu can pose even greater risks. Together, these respiratory...
Anti-estrogen medication reduces risk of dying from lung cancer
January 23, 2011 9:32 pm | by EurekAlert | News | Comments(Wiley-Blackwell) A new study has found that tamoxifen, an anti-estrogen breast cancer medication, may reduce an individual's risk of death from lung cancer. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study supports the hypothesis that...
HEPA filters reduce cardiovascular health risks associated with air pollution
January 21, 2011 8:34 am | by EurekAlert | News | Comments(American Thoracic Society) Using inexpensive air filters may help reduce cardiovascular disease risk that results from exposure to air pollution, according to researchers from Canada, who studied healthy adults living in a small community in British Columbia where wood burning stoves are...
Awake despite anesthesia
January 20, 2011 12:34 pm | by EurekAlert | News | Comments(Deutsches Aerzteblatt International) Unintended awareness during surgery is classified as an occasional complication of anesthesia (one to two in 1,000 patients) -- but being aware of things happening during the operation, and being able to recall them later, can leave a patient with...
Covidien Announces Launch of Puritan Bennett(TM) 520 Portable Ventilator in Europe
January 19, 2011 11:34 pm | by Covidien | News | CommentsNew, easy-to-use mobile respiratory device provides ventilation option for patients transitioning from the hospital to the home BOULDER, Colo., Jan 20, 2011 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in mechanical...
NIH-Funded Study Is First to Demonstrate Increased Long-Term Survival With Favorable Neurologic Function Among Patients Receiving CPR Using ACSI ResQPump® and ResQPOD® CPR D...
January 19, 2011 8:35 am | by Bio-Medicine.Org | News | CommentsROSEVILLE, Minn., Jan. 19, 2011 /- A combination of two devices could save the lives of thousands of cardiac arrest patients each year if implemented nationwide, suggests clinical trial results published in today's online edition of The Lancet. A significantly higher percentage of...
ADVENTRX Pharmaceuticals Receives PDUFA Date for Exelbineâ„¢ NDA
January 19, 2011 3:34 am | by Bio-Medicine.Org | News | CommentsSAN DIEGO, Jan. 19, 2011 /- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ) announced today that the U.S. Food and Drug Administration (FDA) has established a Prescription Drug User Fee Act (PDUFA) date of September 1, 2011 for the review of the Exelbine (ANX-530) New Drug Application...
Bus and tram passengers warned to keep their germs to themselves
January 18, 2011 12:37 pm | by EurekAlert | News | Comments(University of Nottingham) You are six times more likely to end up at the doctors with an acute respiratory infection if you have recently used a bus or tram -- but those who use buses or trams daily might well be somewhat protected compared with more occasional users.
Findings on pollution damage to human airways could yield new therapies
January 17, 2011 8:34 pm | by EurekAlert | News | Comments(Duke University Medical Center) Researchers from Duke University Medical Center have identified how nanoparticles from diesel exhaust damage lung airway cells, a finding that could lead to new therapies for people susceptible to airway disease. The scientists also discovered that the...
Financing Demonstrates Faith in Surgical Sleep Apnea Treatment
January 16, 2011 10:36 pm | by San Diego Business Journal | News | CommentsA San Diego device maker has put to bed more than $8 million of funding to test and develop a pacemakerlike device that could help some sleep apnea sufferers get relief without relying on air masks.
'A stark warning:' Smoking causes genetic damage within minutes after inhaling
January 15, 2011 5:36 pm | by EurekAlert | News | Comments(American Chemical Society) In research described as "a stark warning" to those tempted to start smoking, scientists are reporting that cigarette smoke begins to cause genetic damage within minutes -- not years -- after inhalation into the lungs. Their report, the first human study to...
Dr. Peter J. Pronovost to Join the Board of Directors of Cantel Medical Corp.
January 13, 2011 7:36 am | by Bio-Medicine.Org | News | CommentsLITTLE FALLS, N.J., Jan. 13, 2011 /- Cantel Medical Corp. (NYSE: CMN ) today announced the election of Peter J. Pronovost, M.D., Ph.D. to serve as an independent member of Cantel's Board of Directors. "Dr. Pronovost is a world renowned leader of patient safety and quality, serving as a...
HASCO Medical Signs Agreement With the State of Alabama
January 13, 2011 4:36 am | by Bio-Medicine.Org | News | CommentsMOBILE, Ala., Jan. 13, 2011 /- HASCO Medical, Inc. (OTC Bulletin Board: HASC ), www.mysouthernmed.com , a managed healthcare provider that serves patients in Alabama, Florida, and Mississippi, today announced that Southern Medical & Mobility (SMM), a wholly owned subsidiary of HASCO...
K-V Pharmaceutical Company Updates Status of New Drug Application for Gestivaâ„¢
January 12, 2011 7:35 am | by Bio-Medicine.Org | News | CommentsST. LOUIS, Jan. 12, 2011 /- K-V Pharmaceutical Company (NYSE: KVa/KVb) today issued an update on the status of the U.S. Food and Drug Administration's review of Hologic, Inc.'s (Hologic) New Drug Application (NDA) for Gestiva™ (hydroxyprogesterone caproate injection) as a...
Syndax Announces Publication of Entinostat NSCLC Data in Cancer Research
January 11, 2011 11:35 am | by Bio-Medicine.Org | News | CommentsWALTHAM, Mass., Jan. 11, 2011 /- Syndax, a clinical-stage epigenetics oncology company, announced publication of data of entinostat combined with the demethylating agent Vidaza® (azacitidine) showing effect in reducing tumor burden in differentiated tumor cells in animal tumor models...
Dehaier Medical Announces Participation in Arab Health 2011
January 11, 2011 6:33 am | by Bio-Medicine.Org | News | CommentsBEIJING, Jan. 11, 2011 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM ) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it will...
New research aims to shut down viral assembly line
January 11, 2011 4:33 am | by EurekAlert | News | Comments(Arizona State University) Brenda Hogue and her colleagues at the Biodesign Institute at Arizona State University are studying the intricate formation of coronaviruses. The research may provide fresh insights leading to antiviral agents against viral pathogens like SARS.
Mayo researchers describe measles viral protein movement
January 9, 2011 9:32 am | by EurekAlert | News | Comments(Mayo Clinic) Mayo Clinic researchers have shown that proteins on the surface of a cell twist a viral protein into position, allowing the virus to start infection and cause disease, all in a movement as graceful as a ballroom dance.
